Found 44 hits Enz. Inhib. hit(s) with all data for entry = 3470 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35167
(indazole-benzimidazole, 3)Show SMILES COc1cc(ccc1O)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H26N6O2/c1-31-10-12-32(13-11-31)21-5-3-4-19-25(21)28-26(27-19)24-18-8-6-16(14-20(18)29-30-24)17-7-9-22(33)23(15-17)34-2/h3-9,14-15,33H,10-13H2,1-2H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.26 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35167
(indazole-benzimidazole, 3)Show SMILES COc1cc(ccc1O)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H26N6O2/c1-31-10-12-32(13-11-31)21-5-3-4-19-25(21)28-26(27-19)24-18-8-6-16(14-20(18)29-30-24)17-7-9-22(33)23(15-17)34-2/h3-9,14-15,33H,10-13H2,1-2H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.10 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35190
(pyrazolo[3,4-b]-pyridine, 2)Show SMILES Oc1ccc(cc1)-c1nc2[nH]nc(C(=O)NC3CC3)c2cc1Br Show InChI InChI=1S/C16H13BrN4O2/c17-12-7-11-14(16(23)18-9-3-4-9)20-21-15(11)19-13(12)8-1-5-10(22)6-2-8/h1-2,5-7,9,22H,3-4H2,(H,18,23)(H,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35173
(indazole-benzimidazole, 9)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(N)cc1 Show InChI InChI=1S/C25H25N7/c1-31-11-13-32(14-12-31)22-4-2-3-20-24(22)28-25(27-20)23-19-10-7-17(15-21(19)29-30-23)16-5-8-18(26)9-6-16/h2-10,15H,11-14,26H2,1H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 5.18 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35168
(indazole-benzimidazole, 4)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(O)cc1 Show InChI InChI=1S/C25H24N6O/c1-30-11-13-31(14-12-30)22-4-2-3-20-24(22)27-25(26-20)23-19-10-7-17(15-21(19)28-29-23)16-5-8-18(32)9-6-16/h2-10,15,32H,11-14H2,1H3,(H,26,27)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.60 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35168
(indazole-benzimidazole, 4)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(O)cc1 Show InChI InChI=1S/C25H24N6O/c1-30-11-13-31(14-12-30)22-4-2-3-20-24(22)27-25(26-20)23-19-10-7-17(15-21(19)28-29-23)16-5-8-18(32)9-6-16/h2-10,15,32H,11-14H2,1H3,(H,26,27)(H,28,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 13.3 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35166
(indazole-benzimidazole, 1)Show SMILES COc1cc(O)ccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H26N6O2/c1-31-10-12-32(13-11-31)22-5-3-4-20-25(22)28-26(27-20)24-19-8-6-16(14-21(19)29-30-24)18-9-7-17(33)15-23(18)34-2/h3-9,14-15,33H,10-13H2,1-2H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 22 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35181
(indazole-benzimidazole, 17)Show SMILES COc1cc(N)ccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H27N7O/c1-32-10-12-33(13-11-32)22-5-3-4-20-25(22)29-26(28-20)24-19-8-6-16(14-21(19)30-31-24)18-9-7-17(27)15-23(18)34-2/h3-9,14-15H,10-13,27H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| MMDB PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 23.3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35176
(indazole-benzimidazole, 12)Show SMILES COc1cc(ccc1N)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H27N7O/c1-32-10-12-33(13-11-32)22-5-3-4-20-25(22)29-26(28-20)24-18-8-6-16(14-21(18)30-31-24)17-7-9-19(27)23(15-17)34-2/h3-9,14-15H,10-13,27H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 51.3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35175
(indazole-benzimidazole, 11)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(N)c(F)c1 Show InChI InChI=1S/C25H24FN7/c1-32-9-11-33(12-10-32)22-4-2-3-20-24(22)29-25(28-20)23-17-7-5-16(14-21(17)30-31-23)15-6-8-19(27)18(26)13-15/h2-8,13-14H,9-12,27H2,1H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 55.5 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35166
(indazole-benzimidazole, 1)Show SMILES COc1cc(O)ccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H26N6O2/c1-31-10-12-32(13-11-31)22-5-3-4-20-25(22)28-26(27-20)24-19-8-6-16(14-21(19)29-30-24)18-9-7-17(33)15-23(18)34-2/h3-9,14-15,33H,10-13H2,1-2H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 102 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35176
(indazole-benzimidazole, 12)Show SMILES COc1cc(ccc1N)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H27N7O/c1-32-10-12-33(13-11-32)22-5-3-4-20-25(22)29-26(28-20)24-18-8-6-16(14-21(18)30-31-24)17-7-9-19(27)23(15-17)34-2/h3-9,14-15H,10-13,27H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 247 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35169
(indazole-benzimidazole, 5)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(CO)cc1 Show InChI InChI=1S/C26H26N6O/c1-31-11-13-32(14-12-31)23-4-2-3-21-25(23)28-26(27-21)24-20-10-9-19(15-22(20)29-30-24)18-7-5-17(16-33)6-8-18/h2-10,15,33H,11-14,16H2,1H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 290 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35179
(indazole-benzimidazole, 15)Show SMILES CNc1ccc(cc1)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H27N7/c1-27-19-9-6-17(7-10-19)18-8-11-20-22(16-18)30-31-24(20)26-28-21-4-3-5-23(25(21)29-26)33-14-12-32(2)13-15-33/h3-11,16,27H,12-15H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 585 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35173
(indazole-benzimidazole, 9)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(N)cc1 Show InChI InChI=1S/C25H25N7/c1-31-11-13-32(14-12-31)22-4-2-3-20-24(22)28-25(27-20)23-19-10-7-17(15-21(19)29-30-23)16-5-8-18(26)9-6-16/h2-10,15H,11-14,26H2,1H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MMDB PC cid PC sid PDB UniChem
Patents
Similars
| MMDB PDB Article PubMed
| n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35188
(indazole-benzimidazole, 24)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc2c[nH]nc2c1 Show InChI InChI=1S/C26H24N8/c1-33-9-11-34(12-10-33)23-4-2-3-20-25(23)29-26(28-20)24-19-8-7-17(14-22(19)31-32-24)16-5-6-18-15-27-30-21(18)13-16/h2-8,13-15H,9-12H2,1H3,(H,27,30)(H,28,29)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.07E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35180
(indazole-benzimidazole, 16)Show SMILES CN(C)c1ccc(cc1)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C27H29N7/c1-32(2)20-10-7-18(8-11-20)19-9-12-21-23(17-19)30-31-25(21)27-28-22-5-4-6-24(26(22)29-27)34-15-13-33(3)14-16-34/h4-12,17H,13-16H2,1-3H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.31E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35174
(indazole-benzimidazole, 10)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1cccc(N)c1 Show InChI InChI=1S/C25H25N7/c1-31-10-12-32(13-11-31)22-7-3-6-20-24(22)28-25(27-20)23-19-9-8-17(15-21(19)29-30-23)16-4-2-5-18(26)14-16/h2-9,14-15H,10-13,26H2,1H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.51E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35175
(indazole-benzimidazole, 11)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(N)c(F)c1 Show InChI InChI=1S/C25H24FN7/c1-32-9-11-33(12-10-32)22-4-2-3-20-24(22)29-25(28-20)23-17-7-5-16(14-21(17)30-31-23)15-6-8-19(27)18(26)13-15/h2-8,13-14H,9-12,27H2,1H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.73E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35189
(indazole-benzimidazole, 25)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc2ccoc2c1 Show InChI InChI=1S/C27H24N6O/c1-32-10-12-33(13-11-32)23-4-2-3-21-26(23)29-27(28-21)25-20-8-7-18(15-22(20)30-31-25)19-6-5-17-9-14-34-24(17)16-19/h2-9,14-16H,10-13H2,1H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3.02E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35186
(indazole-benzimidazole, 22)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc2[nH]ccc2c1 Show InChI InChI=1S/C27H25N7/c1-33-11-13-34(14-12-33)24-4-2-3-22-26(24)30-27(29-22)25-20-7-5-18(16-23(20)31-32-25)17-6-8-21-19(15-17)9-10-28-21/h2-10,15-16,28H,11-14H2,1H3,(H,29,30)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.08E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35171
(indazole-benzimidazole, 7)Show SMILES COc1ccccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H26N6O/c1-31-12-14-32(15-13-31)22-8-5-7-20-25(22)28-26(27-20)24-19-11-10-17(16-21(19)29-30-24)18-6-3-4-9-23(18)33-2/h3-11,16H,12-15H2,1-2H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.52E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35174
(indazole-benzimidazole, 10)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1cccc(N)c1 Show InChI InChI=1S/C25H25N7/c1-31-10-12-32(13-11-31)22-7-3-6-20-24(22)28-25(27-20)23-19-9-8-17(15-21(19)29-30-23)16-4-2-5-18(26)14-16/h2-9,14-15H,10-13,26H2,1H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6.10E+3 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35187
(indazole-benzimidazole, 23)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc2ncccc2c1 Show InChI InChI=1S/C28H25N7/c1-34-12-14-35(15-13-34)25-6-2-5-23-27(25)31-28(30-23)26-21-9-7-19(17-24(21)32-33-26)18-8-10-22-20(16-18)4-3-11-29-22/h2-11,16-17H,12-15H2,1H3,(H,30,31)(H,32,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6.84E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35178
(indazole-benzimidazole, 14)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(NC(C)=O)cc1 Show InChI InChI=1S/C27H27N7O/c1-17(35)28-20-9-6-18(7-10-20)19-8-11-21-23(16-19)31-32-25(21)27-29-22-4-3-5-24(26(22)30-27)34-14-12-33(2)13-15-34/h3-11,16H,12-15H2,1-2H3,(H,28,35)(H,29,30)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.80E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35185
(indazole-benzimidazole, 21)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(cc1)S(N)(=O)=O Show InChI InChI=1S/C25H25N7O2S/c1-31-11-13-32(14-12-31)22-4-2-3-20-24(22)28-25(27-20)23-19-10-7-17(15-21(19)29-30-23)16-5-8-18(9-6-16)35(26,33)34/h2-10,15H,11-14H2,1H3,(H,27,28)(H,29,30)(H2,26,33,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.93E+3 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35170
(indazole-benzimidazole, 6)Show SMILES COc1ccc(c(OC)c1)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C27H28N6O2/c1-32-11-13-33(14-12-32)23-6-4-5-21-26(23)29-27(28-21)25-20-9-7-17(15-22(20)30-31-25)19-10-8-18(34-2)16-24(19)35-3/h4-10,15-16H,11-14H2,1-3H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35171
(indazole-benzimidazole, 7)Show SMILES COc1ccccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H26N6O/c1-31-12-14-32(15-13-31)22-8-5-7-20-25(22)28-26(27-20)24-19-11-10-17(16-21(19)29-30-24)18-6-3-4-9-23(18)33-2/h3-11,16H,12-15H2,1-2H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35181
(indazole-benzimidazole, 17)Show SMILES COc1cc(N)ccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H27N7O/c1-32-10-12-33(13-11-32)22-5-3-4-20-25(22)29-26(28-20)24-19-8-6-16(14-21(19)30-31-24)18-9-7-17(27)15-23(18)34-2/h3-9,14-15H,10-13,27H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| MMDB PC cid PC sid PDB UniChem
Similars
| MMDB PDB Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35186
(indazole-benzimidazole, 22)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc2[nH]ccc2c1 Show InChI InChI=1S/C27H25N7/c1-33-11-13-34(14-12-33)24-4-2-3-22-26(24)30-27(29-22)25-20-7-5-18(16-23(20)31-32-25)17-6-8-21-19(15-17)9-10-28-21/h2-10,15-16,28H,11-14H2,1H3,(H,29,30)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35187
(indazole-benzimidazole, 23)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc2ncccc2c1 Show InChI InChI=1S/C28H25N7/c1-34-12-14-35(15-13-34)25-6-2-5-23-27(25)31-28(30-23)26-21-9-7-19(17-24(21)32-33-26)18-8-10-22-20(16-18)4-3-11-29-22/h2-11,16-17H,12-15H2,1H3,(H,30,31)(H,32,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35172
(indazole-benzimidazole, 8)Show SMILES COc1cc(F)ccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H25FN6O/c1-32-10-12-33(13-11-32)22-5-3-4-20-25(22)29-26(28-20)24-19-8-6-16(14-21(19)30-31-24)18-9-7-17(27)15-23(18)34-2/h3-9,14-15H,10-13H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35178
(indazole-benzimidazole, 14)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(NC(C)=O)cc1 Show InChI InChI=1S/C27H27N7O/c1-17(35)28-20-9-6-18(7-10-20)19-8-11-21-23(16-19)31-32-25(21)27-29-22-4-3-5-24(26(22)30-27)34-14-12-33(2)13-15-34/h3-11,16H,12-15H2,1-2H3,(H,28,35)(H,29,30)(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35183
(indazole-benzimidazole, 19)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(cc1)C(C)=O Show InChI InChI=1S/C27H26N6O/c1-17(34)18-6-8-19(9-7-18)20-10-11-21-23(16-20)30-31-25(21)27-28-22-4-3-5-24(26(22)29-27)33-14-12-32(2)13-15-33/h3-11,16H,12-15H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35182
(indazole-benzimidazole, 18)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(cc1)C(O)=O Show InChI InChI=1S/C26H24N6O2/c1-31-11-13-32(14-12-31)22-4-2-3-20-24(22)28-25(27-20)23-19-10-9-18(15-21(19)29-30-23)16-5-7-17(8-6-16)26(33)34/h2-10,15H,11-14H2,1H3,(H,27,28)(H,29,30)(H,33,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35177
(indazole-benzimidazole, 13)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(CN)cc1 Show InChI InChI=1S/C26H27N7/c1-32-11-13-33(14-12-32)23-4-2-3-21-25(23)29-26(28-21)24-20-10-9-19(15-22(20)30-31-24)18-7-5-17(16-27)6-8-18/h2-10,15H,11-14,16,27H2,1H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35184
(indazole-benzimidazole, 20)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(cc1)C(N)=O Show InChI InChI=1S/C26H25N7O/c1-32-11-13-33(14-12-32)22-4-2-3-20-24(22)29-26(28-20)23-19-10-9-18(15-21(19)30-31-23)16-5-7-17(8-6-16)25(27)34/h2-10,15H,11-14H2,1H3,(H2,27,34)(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.18E+4 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35170
(indazole-benzimidazole, 6)Show SMILES COc1ccc(c(OC)c1)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C27H28N6O2/c1-32-11-13-33(14-12-32)23-6-4-5-21-26(23)29-27(28-21)25-20-9-7-17(15-22(20)30-31-25)19-10-8-18(34-2)16-24(19)35-3/h4-10,15-16H,11-14H2,1-3H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.24E+4 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35183
(indazole-benzimidazole, 19)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(cc1)C(C)=O Show InChI InChI=1S/C27H26N6O/c1-17(34)18-6-8-19(9-7-18)20-10-11-21-23(16-20)30-31-25(21)27-28-22-4-3-5-24(26(22)29-27)33-14-12-32(2)13-15-33/h3-11,16H,12-15H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.36E+4 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35172
(indazole-benzimidazole, 8)Show SMILES COc1cc(F)ccc1-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H25FN6O/c1-32-10-12-33(13-11-32)22-5-3-4-20-25(22)29-26(28-20)24-19-8-6-16(14-21(19)30-31-24)18-9-7-17(27)15-23(18)34-2/h3-9,14-15H,10-13H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35169
(indazole-benzimidazole, 5)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(CO)cc1 Show InChI InChI=1S/C26H26N6O/c1-31-11-13-32(14-12-31)23-4-2-3-21-25(23)28-26(27-21)24-20-10-9-19(15-22(20)29-30-24)18-7-5-17(16-33)6-8-18/h2-10,15,33H,11-14,16H2,1H3,(H,27,28)(H,29,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.15E+4 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35182
(indazole-benzimidazole, 18)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(cc1)C(O)=O Show InChI InChI=1S/C26H24N6O2/c1-31-11-13-32(14-12-31)22-4-2-3-20-24(22)28-25(27-20)23-19-10-9-18(15-21(19)29-30-23)16-5-7-17(8-6-16)26(33)34/h2-10,15H,11-14H2,1H3,(H,27,28)(H,29,30)(H,33,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 2.73E+4 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Protein kinase C zeta type
(Homo sapiens (Human)) | BDBM35177
(indazole-benzimidazole, 13)Show SMILES CN1CCN(CC1)c1cccc2[nH]c(nc12)-c1n[nH]c2cc(ccc12)-c1ccc(CN)cc1 Show InChI InChI=1S/C26H27N7/c1-32-11-13-33(14-12-32)23-4-2-3-21-25(23)29-26(28-21)24-20-10-9-19(15-22(20)30-31-24)18-7-5-17(16-27)6-8-18/h2-10,15H,11-14,16,27H2,1H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 3.11E+4 | n/a | n/a | n/a | n/a | 7.5 | 23 |
Pfizer
| Assay Description Protein kinase C (PKC), zeta activity was measured by following the phosphorylation of a biotinylated peptide substrate in the presence of ATP using ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | |
Cyclin-A2 [177-432]/Cyclin-dependent kinase 2
(Homo sapiens (Human)) | BDBM35179
(indazole-benzimidazole, 15)Show SMILES CNc1ccc(cc1)-c1ccc2c(n[nH]c2c1)-c1nc2c(cccc2[nH]1)N1CCN(C)CC1 Show InChI InChI=1S/C26H27N7/c1-27-19-9-6-17(7-10-19)18-8-11-20-22(16-18)30-31-24(20)26-28-21-4-3-5-23(25(21)29-26)33-14-12-32(2)13-15-33/h3-11,16,27H,12-15H2,1-2H3,(H,28,29)(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.09E+5 | n/a | n/a | n/a | n/a | n/a | 25 |
Pfizer
| Assay Description Active cyclin dependent kinase 2 (CDK2) activity was determined by measuring the phosphorylation of Histone type 3 (Sigma H5505), in the presence of ... |
Bioorg Med Chem Lett 19: 908-11 (2009)
Article DOI: 10.1016/j.bmcl.2008.11.105 BindingDB Entry DOI: 10.7270/Q2G73C1H |
More data for this Ligand-Target Pair | 3D Structure (docked) |